Aug 13 |
Orchestra BioMed reports Q2 results
|
Aug 12 |
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Lags Revenue Estimates
|
Aug 12 |
Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update
|
Aug 8 |
Orchestra BioMed Holdings, Inc. (OBIO) Loses -25.35% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
|
Aug 1 |
Orchestra BioMed Holdings, Inc. (OBIO) Expected to Beat Earnings Estimates: Should You Buy?
|
Jul 30 |
Orchestra BioMed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board of Directors
|
Jul 23 |
Precision Neuroscience Expands Executive Team as Brain–Computer Interface Industry Rapidly Advances
|
Jun 18 |
Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) largest shareholders are individual investors with 37% ownership, public companies own 16%
|
May 15 |
Orchestra BioMed reports Q1 results
|
May 13 |
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Misses Revenue Estimates
|